Click here to get full coverage on (AUPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

(AUPH) Movement Within Algorithmic Entry Frameworks  Stock Traders Daily

(AUPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Click here to get full coverage on AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill

AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH)  ChartMill

AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025 - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025 - Yahoo Finance

Click here to get full coverage on A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Its Recent Leadership Overhaul - simplywall.st

A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Its Recent Leadership Overhaul  simplywall.st

A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Its Recent Leadership Overhaul - simplywall.st

Click here to get full coverage on AURINIA PHARMACEUTICALS ($AUPH) Releases Q4 2025 Earnings - Quiver Quantitative

AURINIA PHARMACEUTICALS ($AUPH) Releases Q4 2025 Earnings  Quiver Quantitative

AURINIA PHARMACEUTICALS ($AUPH) Releases Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on Investors - Aurinia Pharmaceuticals Inc.

Investors  Aurinia Pharmaceuticals Inc.

Investors - Aurinia Pharmaceuticals Inc.

Click here to get full coverage on AUPH stock rallies after CEO shake-up: Retail bulls bet on turnaround - MSN

AUPH stock rallies after CEO shake-up: Retail bulls bet on turnaround  MSN

AUPH stock rallies after CEO shake-up: Retail bulls bet on turnaround - MSN

Click here to get full coverage on Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs - Stock Titan

Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs  Stock Titan

Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs - Stock Titan

Click here to get full coverage on AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) Screens Strong on Minervini Trend Template and High Growth Momentum - ChartMill

AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) Screens Strong on Minervini Trend Template and High Growth Momentum  ChartMill

AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) Screens Strong on Minervini Trend Template and High Growth Momentum - ChartMill

Click here to get full coverage on Investing in Aurinia Pharmaceuticals (NASDAQ:AUPH) a year ago would have delivered you a 80% gain - Yahoo Finance

Investing in Aurinia Pharmaceuticals (NASDAQ:AUPH) a year ago would have delivered you a 80% gain  Yahoo Finance

Investing in Aurinia Pharmaceuticals (NASDAQ:AUPH) a year ago would have delivered you a 80% gain - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $AUPH Given $16 Price Target - Quiver Quantitative

New Analyst Forecast: $AUPH Given $16 Price Target  Quiver Quantitative

New Analyst Forecast: $AUPH Given $16 Price Target - Quiver Quantitative

Click here to get full coverage on Is Aurinia Pharmaceuticals (AUPH) Pricing Reflect Long Term Value After 71% One Year Gain - Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Pricing Reflect Long Term Value After 71% One Year Gain  Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Pricing Reflect Long Term Value After 71% One Year Gain - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on With 54% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance

With 54% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns  Yahoo Finance

With 54% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance

Click here to get full coverage on Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates?  Yahoo Finance

Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Click here to get full coverage on Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - Yahoo Finance

What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now?  Yahoo Finance

What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge - Yahoo Finance

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge  Yahoo Finance

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge - Yahoo Finance

Click here to get full coverage on Should Aurinia’s Surging 2025 Earnings and Upbeat 2026 Outlook Require Action From Aurinia (AUPH) Investors? - Yahoo Finance

Should Aurinia’s Surging 2025 Earnings and Upbeat 2026 Outlook Require Action From Aurinia (AUPH) Investors?  Yahoo Finance

Should Aurinia’s Surging 2025 Earnings and Upbeat 2026 Outlook Require Action From Aurinia (AUPH) Investors? - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals: Waiting For Another Opportunity (Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharmaceuticals: Waiting For Another Opportunity (Downgrade) (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharmaceuticals: Waiting For Another Opportunity (Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates - Stocktwits

AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates  Stocktwits

AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates - Stocktwits

Click here to get full coverage on Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on Aurinia (NASDAQ: AUPH) installs Kevin Tang as CEO amid broad C-suite exits - Stock Titan

Aurinia (NASDAQ: AUPH) installs Kevin Tang as CEO amid broad C-suite exits  Stock Titan

Aurinia (NASDAQ: AUPH) installs Kevin Tang as CEO amid broad C-suite exits - Stock Titan

Click here to get full coverage on Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year?  Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Passes Key Growth Screener from "The Little Book That Makes You Rich" - ChartMill

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Passes Key Growth Screener from "The Little Book That Makes You Rich"  ChartMill

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Passes Key Growth Screener from "The Little Book That Makes You Rich" - ChartMill

Click here to get full coverage on Aurinia (AUPH) CMO awarded new stock options and share grant - Stock Titan

Aurinia (AUPH) CMO awarded new stock options and share grant  Stock Titan

Aurinia (AUPH) CMO awarded new stock options and share grant - Stock Titan

Click here to get full coverage on Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified - simplywall.st

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified  simplywall.st

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Earnings Spike Above Revenue Challenges Profit Quality Narratives - simplywall.st

Aurinia Pharmaceuticals (AUPH) Earnings Spike Above Revenue Challenges Profit Quality Narratives  simplywall.st

Aurinia Pharmaceuticals (AUPH) Earnings Spike Above Revenue Challenges Profit Quality Narratives - simplywall.st

Click here to get full coverage on AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH): A High-Growth Momentum and Technical Trend Case Study - ChartMill

AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH): A High-Growth Momentum and Technical Trend Case Study  ChartMill

AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH): A High-Growth Momentum and Technical Trend Case Study - ChartMill

Click here to get full coverage on Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - simplywall.st

Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks  simplywall.st

Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on Tang Capital boosts Aurinia (AUPH) stake to 9.2% ownership - Stock Titan

Tang Capital boosts Aurinia (AUPH) stake to 9.2% ownership  Stock Titan

Tang Capital boosts Aurinia (AUPH) stake to 9.2% ownership - Stock Titan

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) COO Ryan Cole becomes SEC Form 3 insider - Stock Titan

Aurinia Pharmaceuticals (AUPH) COO Ryan Cole becomes SEC Form 3 insider  Stock Titan

Aurinia Pharmaceuticals (AUPH) COO Ryan Cole becomes SEC Form 3 insider - Stock Titan

Click here to get full coverage on Aurinia (NASDAQ: AUPH) CEO receives major option grant and withholds shares for taxes - Stock Titan

Aurinia (NASDAQ: AUPH) CEO receives major option grant and withholds shares for taxes  Stock Titan

Aurinia (NASDAQ: AUPH) CEO receives major option grant and withholds shares for taxes - Stock Titan

Click here to get full coverage on Mutiny At Aurinia Pharmaceuticals? Biotech Rallies On C-Suite Shake-Up - Investor's Business Daily

Mutiny At Aurinia Pharmaceuticals? Biotech Rallies On C-Suite Shake-Up  Investor's Business Daily

Mutiny At Aurinia Pharmaceuticals? Biotech Rallies On C-Suite Shake-Up - Investor's Business Daily

Click here to get full coverage on Does Aurinia’s Tang‑Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)? - Yahoo Finance

Does Aurinia’s Tang‑Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)?  Yahoo Finance

Does Aurinia’s Tang‑Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)? - Yahoo Finance

Click here to get full coverage on [SCHEDULE 13D/A] Aurinia Pharmaceuticals Inc. Amended Major Shareholder Report - Stock Titan

[SCHEDULE 13D/A] Aurinia Pharmaceuticals Inc. Amended Major Shareholder Report  Stock Titan

[SCHEDULE 13D/A] Aurinia Pharmaceuticals Inc. Amended Major Shareholder Report - Stock Titan

Click here to get full coverage on Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know  Yahoo Finance

Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Click here to get full coverage on How Aurinia Pharmaceuticals Inc (AUPH) Affects Rotational Strategy Timing - Stock Traders Daily

How Aurinia Pharmaceuticals Inc (AUPH) Affects Rotational Strategy Timing  Stock Traders Daily

How Aurinia Pharmaceuticals Inc (AUPH) Affects Rotational Strategy Timing - Stock Traders Daily

Click here to get full coverage on How Aurinia’s Tang-Led C-Suite Overhaul Will Impact Aurinia Pharmaceuticals (AUPH) Investors - simplywall.st

How Aurinia’s Tang-Led C-Suite Overhaul Will Impact Aurinia Pharmaceuticals (AUPH) Investors  simplywall.st

How Aurinia’s Tang-Led C-Suite Overhaul Will Impact Aurinia Pharmaceuticals (AUPH) Investors - simplywall.st

Click here to get full coverage on Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning - Benzinga

Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning  Benzinga

Why Aurinia Pharmaceuticals Stock Is Surging Monday Morning - Benzinga

Click here to get full coverage on MSN Money - MSN

MSN Money - MSN

Click here to get full coverage on Technical Reactions to AUPH Trends in Macro Strategies - Stock Traders Daily

Technical Reactions to AUPH Trends in Macro Strategies  Stock Traders Daily

Technical Reactions to AUPH Trends in Macro Strategies - Stock Traders Daily

Click here to get full coverage on $AUPH stock is down 18% today. Here's what we see in our data. - Quiver Quantitative

$AUPH stock is down 18% today. Here's what we see in our data.  Quiver Quantitative

$AUPH stock is down 18% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Business Wire

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right  Business Wire

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Business Wire

Click here to get full coverage on Aurinia Announces Management Transition - Business Wire

Aurinia Announces Management Transition  Business Wire

Aurinia Announces Management Transition - Business Wire

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) CFO Michael Hearne becomes reporting insider with Form 3 - Stock Titan

Aurinia Pharmaceuticals (AUPH) CFO Michael Hearne becomes reporting insider with Form 3  Stock Titan

Aurinia Pharmaceuticals (AUPH) CFO Michael Hearne becomes reporting insider with Form 3 - Stock Titan

Click here to get full coverage on Aurinia Pharmaceuticals Inc (AUPH) Investor Outlook: Exploring A 21.60% Upside Potential - DirectorsTalk Interviews

Aurinia Pharmaceuticals Inc (AUPH) Investor Outlook: Exploring A 21.60% Upside Potential  DirectorsTalk Interviews

Aurinia Pharmaceuticals Inc (AUPH) Investor Outlook: Exploring A 21.60% Upside Potential - DirectorsTalk Interviews

Click here to get full coverage on Precision Trading with Aurinia Pharmaceuticals Inc (AUPH) Risk Zones - Stock Traders Daily

Precision Trading with Aurinia Pharmaceuticals Inc (AUPH) Risk Zones  Stock Traders Daily

Precision Trading with Aurinia Pharmaceuticals Inc (AUPH) Risk Zones - Stock Traders Daily

Click here to get full coverage on Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ) - Seeking Alpha

Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ)  Seeking Alpha

Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ) - Seeking Alpha

Click here to get full coverage on Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026 - Business Wire

Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026  Business Wire

Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026 - Business Wire

Click here to get full coverage on Aurinia Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance

Aurinia Pharmaceuticals Q4 Earnings Call Highlights  Yahoo Finance

Aurinia Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering The 9.51% Potential Upside - DirectorsTalk Interviews

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering The 9.51% Potential Upside  DirectorsTalk Interviews

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering The 9.51% Potential Upside - DirectorsTalk Interviews

Click here to get full coverage on Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating - Seeking Alpha

Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating  Seeking Alpha

Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating - Seeking Alpha

Click here to get full coverage on Trading the Move, Not the Narrative: (AUPH) Edition - Stock Traders Daily

Trading the Move, Not the Narrative: (AUPH) Edition  Stock Traders Daily

Trading the Move, Not the Narrative: (AUPH) Edition - Stock Traders Daily

Click here to get full coverage on This Pharma Stock With Earnings Seen Soaring 1,854% Forms Bullish Base - Investor's Business Daily

This Pharma Stock With Earnings Seen Soaring 1,854% Forms Bullish Base  Investor's Business Daily

This Pharma Stock With Earnings Seen Soaring 1,854% Forms Bullish Base - Investor's Business Daily

Click here to get full coverage on Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress - Yahoo Finance

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress  Yahoo Finance

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress - Yahoo Finance

Click here to get full coverage on Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on How (AUPH) Movements Inform Risk Allocation Models - Stock Traders Daily

How (AUPH) Movements Inform Risk Allocation Models  Stock Traders Daily

How (AUPH) Movements Inform Risk Allocation Models - Stock Traders Daily

Click here to get full coverage on Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha

Aurinia responds after top FDA official’s comment on lead drug  Seeking Alpha

Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha

Click here to get full coverage on Insider Purchase: Director at $AUPH Buys 1,000,000 Shares - Quiver Quantitative

Insider Purchase: Director at $AUPH Buys 1,000,000 Shares  Quiver Quantitative

Insider Purchase: Director at $AUPH Buys 1,000,000 Shares - Quiver Quantitative

Click here to get full coverage on Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - Yahoo Finance

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?  Yahoo Finance

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - Yahoo Finance

Click here to get full coverage on Responsive Playbooks and the AUPH Inflection - Stock Traders Daily

Responsive Playbooks and the AUPH Inflection  Stock Traders Daily

Responsive Playbooks and the AUPH Inflection - Stock Traders Daily

Click here to get full coverage on Aurinia Pharmaceuticals Inc expected to post earnings of 22 cents a share - Earnings Preview - TradingView

Aurinia Pharmaceuticals Inc expected to post earnings of 22 cents a share - Earnings Preview  TradingView

Aurinia Pharmaceuticals Inc expected to post earnings of 22 cents a share - Earnings Preview - TradingView

Click here to get full coverage on AURINIA PHARMACEUTICALS Earnings Results: $AUPH Reports Quarterly Earnings - Quiver Quantitative

AURINIA PHARMACEUTICALS Earnings Results: $AUPH Reports Quarterly Earnings  Quiver Quantitative

AURINIA PHARMACEUTICALS Earnings Results: $AUPH Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH)  Seeking Alpha

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook - The Globe and Mail

Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook  The Globe and Mail

AUPH

Price Chart

Key Statistics

Technicals

About AUPH

Latest News

(AUPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill

Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025 - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers